| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...864947H |
| P356 | DOI | 10.1371/JOURNAL.PONE.0064947 |
| P932 | PMC publication ID | 3672143 |
| P698 | PubMed publication ID | 23750220 |
| P5875 | ResearchGate publication ID | 237093664 |
| P50 | author | Katharina Domschke | Q21264133 |
| Bertram Müller-Myhsok | Q29840612 | ||
| Susanne Lucae | Q91202903 | ||
| Volker Arolt | Q110551284 | ||
| Sonja Horstmann | Q125269120 | ||
| Tanja Brückl | Q125269447 | ||
| Darina Czamara | Q37356516 | ||
| Manfred Uhr | Q37358811 | ||
| Marcus Ising | Q37361882 | ||
| Torsten Klengel | Q42875669 | ||
| Andreas Menke | Q47809940 | ||
| Angela Heck | Q47816002 | ||
| Christiane Wolf | Q90469606 | ||
| P2093 | author name string | Bernhard T Baune | |
| Anne Eckert | |||
| Martin A Kohli | |||
| Maria Giese | |||
| Johannes M Hennings | |||
| P2860 | cites work | Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment | Q24546379 |
| Brain-derived neurotrophic factor: role in depression and suicide | Q24647110 | ||
| The structure of haplotype blocks in the human genome | Q27860500 | ||
| Haploview: analysis and visualization of LD and haplotype maps | Q27860955 | ||
| Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment | Q28295248 | ||
| Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. | Q29417150 | ||
| Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies | Q29614926 | ||
| Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report | Q29615999 | ||
| A neurotrophic model for stress-related mood disorders | Q29616291 | ||
| Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans | Q33710367 | ||
| Population genetic study of the brain-derived neurotrophic factor (BDNF) gene | Q33926241 | ||
| The corticosteroid receptor hypothesis of depression | Q34057906 | ||
| Problems of reporting genetic associations with complex outcomes | Q34184173 | ||
| Neurotrophins as synaptic modulators | Q34186265 | ||
| BDNF Val66Met genotype and 6-month remission rates in late-life depression | Q34233144 | ||
| Patterns of cis regulatory variation in diverse human populations | Q34244935 | ||
| Is it time to reassess the BDNF hypothesis of depression? | Q34663655 | ||
| Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression | Q34740072 | ||
| Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response | Q34743434 | ||
| Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone | Q34806426 | ||
| A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression | Q35737324 | ||
| The bipolar spectrum and the antidepressant view of the world | Q36180345 | ||
| Association of genetic variants in the neurotrophic receptor-encoding gene NTRK2 and a lifetime history of suicide attempts in depressed patients | Q36965978 | ||
| Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies | Q36976169 | ||
| Diagnostic guidelines for bipolar depression: a probabilistic approach | Q37058580 | ||
| The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. | Q37219127 | ||
| Brain-derived neurotrophic factor and antidepressant action: another piece of evidence from pharmacogenetics | Q37264563 | ||
| Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project | Q38476657 | ||
| Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity | Q40036871 | ||
| Rational inferences about departures from Hardy-Weinberg equilibrium | Q41826873 | ||
| A note on the calculation of empirical P values from Monte Carlo procedures. | Q43202630 | ||
| Increased stress reactivity is associated with cognitive deficits and decreased hippocampal brain-derived neurotrophic factor in a mouse model of affective disorders | Q43207305 | ||
| Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients | Q43218136 | ||
| Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions | Q43922336 | ||
| Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. | Q44270223 | ||
| Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior | Q44691711 | ||
| SNPs in neurotrophin system genes and Alzheimer's disease in an Italian population | Q44865775 | ||
| No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study. | Q45035951 | ||
| Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. | Q45916412 | ||
| Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression. | Q45984035 | ||
| Genetic predictors of response to antidepressants in the GENDEP project | Q46051862 | ||
| Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response | Q46112497 | ||
| Suppressive effect of mirtazapine on the HPA system in acutely depressed women seems to be transient and not related to antidepressant action | Q46313005 | ||
| Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine | Q46482293 | ||
| A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders. | Q48166495 | ||
| A splice site polymorphism in the G-protein beta subunit influences antidepressant efficacy in depression | Q48187724 | ||
| Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain | Q48266494 | ||
| Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone. | Q48345283 | ||
| The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine | Q48375775 | ||
| Gene-gene interactions of the brain-derived neurotrophic-factor and neurotrophic tyrosine kinase receptor 2 genes in geriatric depression | Q48377411 | ||
| Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder | Q48411017 | ||
| Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder | Q48419893 | ||
| Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism | Q48440447 | ||
| The effects of acute and long-term lithium treatments on trkB neurotrophin receptor activation in the mouse hippocampus and anterior cingulate cortex | Q48689480 | ||
| Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression | Q48819378 | ||
| Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder | Q48941703 | ||
| The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: a pilot study | Q49073147 | ||
| Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder | Q51736448 | ||
| Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments | Q52012874 | ||
| Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus | Q52017804 | ||
| Combined Dexamethasone/Corticotropin Releasing Hormone Test Predicts Treatment Response in Major Depression–A Potential Biomarker? | Q60631384 | ||
| Association study of neurotrophic tyrosine kinase receptor type 2 (NTRK2) and childhood-onset mood disorders | Q61570858 | ||
| Association of the COMT val158met variant with antidepressant treatment response in major depression | Q80376629 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e64947 | |
| P577 | publication date | 2013-06-04 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Possible associations of NTRK2 polymorphisms with antidepressant treatment outcome: findings from an extended tag SNP approach | |
| P478 | volume | 8 |
| Q94464650 | An Analysis of Five TrkB Gene Polymorphisms in Schizophrenia and the Interaction of Its Haplotype with rs6265 BDNF Gene Polymorphism |
| Q90857194 | BDNF genetic variants and methylation: effects on cognition in major depressive disorder |
| Q38540142 | BDNF/TRKB/P75NTR polymorphisms and their consequences on antidepressant efficacy in depressed patients. |
| Q40314455 | No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients. |
| Q38983579 | Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies. |
| Q47666907 | Progress in Elucidating Biomarkers of Antidepressant Pharmacological Treatment Response: A Systematic Review and Meta-analysis of the Last 15 Years |
| Q34424865 | Understanding the pharmacogenetics of selective serotonin reuptake inhibitors |
Search more.